Skip to content

A Retrospective Data Collection on NobelProcera® Zirconia Implant Bridges from 4 to 14 Units.

A Retrospective Multicenter Clinical Data Collection to Evaluate the Safety, Performance, and Clinical Benefits of NobelProcera® Zirconia Implant Bridges from 4 to 14 Units in Daily Dental Practice

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06600451
Enrollment
200
Registered
2024-09-19
Start date
2024-01-02
Completion date
2024-12-31
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Prosthesis, Implant-Supported

Keywords

dental prosthesis, NobelProcera, implant supported prosthesis, zirconia bridge

Brief summary

This is a retrospective multicenter data collection in which clinical and radiographic data on implant zirconia bridges are collected from partially or fully edentulous subjects consecutively treated with at least one 4- to 14-unit NobelProcera® Zirconia Implant Bridge. This data collection will be conducted in up to 11 centers (see Appendix I) and will include between 150 to 200 subjects. The aim of this retrospective multicenter data collection is to evaluate the safety, performance, and clinical benefits of NobelProcera® Zirconia Implant Bridges (4 to 14 units) in daily dental practice.

Interventions

OTHERobservational study, no intervention is required

Retrospective chart review, investigators provides data after reviewing patient's existing medical record; no interaction with patients is required. Patients were treated as per standard of care

Sponsors

Nobel Biocare
Lead SponsorINDUSTRY

Study design

Observational model
OTHER
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Subject was at least 18 years old at the time of treatment, * Subjects treated with at least one NobelProcera® Zirconia Implant Bridge (4- to 14-unit supported by 2 to 10 implants).

Exclusion criteria

* none

Design outcomes

Primary

MeasureTime frameDescription
complicationsfrom bridge placement to last follow-up (up to 36 months follow-up)biological and technical complications

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026